News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Travere Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
Business
Retrophin Booted CEO For Multiple Stock Violations: Report
October 3, 2014
·
2 min read
Biotech Bay
Retrophin, Inc., Gilead Sciences, Inc., And Our Healthcare Values
September 15, 2014
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Biotech Beach
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 11, 2023
October 11, 2023
·
1 min read
Biotech Beach
Travere Therapeutics to Present Abstracts at the 17th International Symposium on IgA Nephropathy (IIGANN 2023)
September 26, 2023
·
12 min read
Drug Development
Travere Therapeutics Announces Confirmatory Data from the Phase 3 PROTECT Study of FILSPARI® Demonstrating Long-Term Kidney Function Preservation in IgA Nephropathy; Narrowly Missing eGFR Total Slope Endpoint versus Active Control, Irbesartan
September 21, 2023
·
19 min read
Biotech Beach
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 11, 2023
September 11, 2023
·
1 min read
Deals
Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics
September 5, 2023
·
11 min read
Biotech Bay
Travere Therapeutics Completes Sale of Bile Acid Product Portfolio to Mirum Pharmaceuticals
September 5, 2023
·
11 min read
Biotech Beach
Travere Therapeutics to Present at the 2023 Wells Fargo Healthcare Conference
August 31, 2023
·
1 min read
Biotech Beach
Travere Therapeutics to Present Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023
August 24, 2023
·
6 min read
Biotech Beach
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 14, 2023
August 14, 2023
·
1 min read
Business
Travere Therapeutics Reports Second Quarter 2023 Financial Results
August 3, 2023
·
25 min read
